Compare iShares Core MSCI EAFE ETF (IEFA) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core MSCI EAFE ETF vs Oruka Therapeutics Inc. Common Stock — how do they compare? iShares Core MSCI EAFE ETF trades at $96.01 (market cap $188.50B), while Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B). The key difference: iShares Core MSCI EAFE ETF is far larger — about 37.1× Oruka Therapeutics Inc. Common Stock's market cap, and Oruka Therapeutics Inc. Common Stock is more actively traded (685,276 versus 5,885,862). Which is the better fit depends on your goals — on Pluang, investors hold iShares Core MSCI EAFE ETF for 41 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| IEFA | ORKA | |
|---|---|---|
Market Cap | $188.50B | $5.08B |
Volume | 5,885,862 | 685,276 |
Sector | Broad Market / Factor | Health |
52-Week High | $101.41 | $113.08 |
52-Week Low | $85.06 | $26.19 |
Typical Hold Time | 41 Days | 0 Days |
Enterprise Value | — | $4.21B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares Core MSCI EAFE ETF
IEFA tracks the MSCI EAFE Investable Market Index, offering broad exposure to large, mid, and small-cap stocks in developed markets across Europe, Australasia, and the Far East. It serves as a low-cost core holding for international diversification, excluding the U.S. and Canada.
Read more on IEFA →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
